FeesSafety
Pluang+

Sono Group swings to $0.6M net income in Q3 2026 as a Bitcoin treasury company.

Company Fundamentals
10 Nov 2026, 13:30 WIB
GlobeNewsWire
View Source
Bullish
Sono Group swings to $0.6M net income in Q3 2026 as a Bitcoin treasury company.

Sono Group reported a net income of $0.6 million in Q3 2026, reversing a $1.4 million loss in the same quarter last year, driven by Bitcoin treasury income and fair-value gains. This quarter marks their first full quarter operating solely as a Bitcoin treasury company after selling their solar business. The company plans a shareholder vote in December on moving its legal domicile to Delaware to simplify its corporate structure and pursue strategic opportunities. Sono also announced a potential business combination with Sports One, focusing on sports franchise investments, though this deal is not yet finalized.

Sono Group N.V. reports its third quarter 2026 results as context for readers. On Pluang, 77 of 150 priced US stocks rose while 65 fell as of Nov 10, 2026 17:11 WIB. Notable prices include Newmont Corporation at USD 122.70 with a 1-day change of -1.97%, Barclays PLC at USD 23.61 up 1.81%, and Nvidia Corp at USD 181.77 rising 1.74%.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
59 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
59 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
59 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
59 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App